Amphenol (APH) Cash & Equivalents (2009 - 2026)

Amphenol has reported Cash & Equivalents for 18 years, with the latest figure at $5.4 billion in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $5.4 billion, up 67.96% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.4 billion (up 67.96% YoY), and the FY2025 annual result was $11.4 billion, up 242.81% from the prior year.
• Cash & Equivalents grew to $5.4 billion in Q2 2026, from $4.6 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $11.4 billion in Q4 2025 and troughed at $1.3 billion in Q3 2022.
• A 5-year average of $2.8 billion and a median of $1.7 billion in 2023 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2022, when Cash & Equivalents tumbled 44.96%; it then surged 242.81% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $1.4 billion in 2022, then rose by 15.76% to $1.7 billion in 2023, then soared by 100.9% to $3.3 billion in 2024, then surged by 242.81% to $11.4 billion in 2025, then slumped by 52.61% to $5.4 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $5.4 billion in Q2 2026, $4.6 billion in Q1 2026, and $11.4 billion in Q4 2025.